← Open Payments lookup

CASEY MCGRATH: Open Payments

NPI 1821632324 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,125 in 108 payments from 20 companies in 2025. Trend: 2023 $1,836 · 2024 $1,920 · 2025 $2,125

Food & beverage: $2,125
CompanyPaymentsAmount
ABBVIE INC.22$375
GlaxoSmithKline, LLC.12$296
Novo Nordisk Inc12$251
Lilly USA, LLC8$174
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$150
AstraZeneca Pharmaceuticals LP8$141
PFIZER INC.12$137
Astellas Pharma US Inc3$104
Otsuka America Pharmaceutical, Inc.4$89
Kowa Pharmaceuticals America, Inc.4$73

Products named: TRELEGY ELLIPTA, VRAYLAR, MOUNJARO, Ozempic, REXULTI, CAPLYTA, Veozah, QULIPTA.

Industry payments across PA — which companies pay providers there.